Biotech firm Blis Technologies, which sells a number of probiotic products that are said to boost immunity, has had a sharp increase in sales in the wake of Covid-19.
The big sales increase has boosted the company’s revenue expectations to near $10 million for the year to March 31 from $9.4m
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive FREE offer for uni students studying at a New Zealand university (valued at $499).
